New Virttu Biologics Replicate Open Innovation Forum Provides Unique R&D Network for New Oncology Combination Therapies
11/5/2012 12:10:50 PM
More...
|
Oncolytic Virus Specialist Virttu Biologics Initiates Phase I/II SEPREHVIR™ Study in Mesothelioma
9/11/2012 11:31:41 AM
More...
|